The Agar lab
Drug Discovery for fALS and Analytical Chemistry Studies
The Agar group characterizes post-translational modifications of proteins and changes in protein, peptide, and lipid expression that occur during ALS, and then determines which of these changes have structural or toxic consequences. We use a variety of techniques but are best known for our contributions to top-down mass spectrometry development. We are now developing a potential drug for ALS based upon these studies.
Jeffrey N. Agar
Associate Dean of Professional Programs and Lifelong Learning and Associate Professor
Chemistry and Chemical Biology, Barnett Institute for Chemical & Biological Analysis
Bouve College of Health Sciences
Our Team
Our Ph.D. Students
Novera Alam
5th year Ph.D. Candidate
Rutali Brahme
5th year PhD Candidate
Wensheng Yang
4th year Ph.D. Candidate
Durgalakshmi Sivasankar
3rd year Ph.D. Candidate
Christopher Singleton
3rd year PhD Student
David E. Verrill
2nd year Ph.D. Student
Our Alumni
Md Amin Hossain
Ph.D.
Richa Sarin
Ph.D.
Krishna C. Aluri
Ph.D.
Nicholas Schmitt
Ph.D.
Daniel Donnelly
Ph.D.
Catherine Rawlins
Ph.D.
Jeniffer Quijada
Ph.D.
Joseph Salisbury
Ph.D.
Qian Liu
Ph.D.
Josh Johnson
Ph.D.
Qi Wang
Ph.D.
Murat Karabacak
Ph.D.
Kristin Boggio
Ph.D.
Jennifer Stroka-Cobb
Ph.D.